Skip to main content

Upcoming presentations/meetings

2023-02-07
Year-end report 2022
2023-03-07
Redeye - Theme: Commercialisation
2023-03-17
AAD Annual Meeting, New Orleans
2023-03-30
Swiss Nordic Bio, Zürich
2023-05-09
Interim report for January - March 2023
2023-05-10
Redeye Investor Forum
2023-05-16
Annual General Meeting of Moberg Pharma
2023-05-16
Annual General Meeting of Moberg Pharma
2023-06-01
Redeye Growth Day
2023-08-15
Interim report for January - June 2023
2023-08-31
Redeye Investor Forum Online
2023-11-07
Interim report för January - September 2023
2023-11-23
Redeye Life Science Day

Previous presentations/meetings

2022-11-24
Redeye Life Science Day
2022-11-15
CEO Interview with Anna Ljung
2022-11-08
Interim report for January - September 2022
2022-09-01
Redeye Investor Forum
2022-08-31
Aktiespararnas digital Life Science Day
2022-08-09
Interim report for January - June 2022
2022-08-09
CEO Interview with Anna Ljung
2022-05-10
CEO Interview with Anna Ljung
2022-05-10
Interim report for January - March 2022
2022-05-05
Redeye Investor Forum
2022-03-25
AAD Annual Meeting, Boston, MA, 25-29 March
2022-03-08
SCF Life Science Corporate Finance Day, Stockholm
2022-02-24
Redeye Investor Forum
2022-02-09
CEO Interview with Anna Ljung
2022-02-08
Year-end report for the financial year 2021
2021-12-09
Redeye Investor Forum
2021-11-11
Redeye Life Science Day
2021-11-09
CEO Interview with Anna Ljung

 

2021-11-09
Interim report for January - September 2021

2021-10-07
Vator Securities - Healthcare Innovation Summit
2021-09-02
Redeye Investor Forum
2021-09-01
Pareto Securities Annual Healthcare Conference
2021-08-10
Interim report for January - June 2021

2021-06-02
Redeye Growth Day
2021-05-26
BioStock Life Science Summit
2021-05-11
Redeye Investor Forum
2021-05-11
CEO Interview with Anna Ljung

2021-05-11
Interim report for January - March 2021

2021-03-25
Redeye Investor Forum
2021-02-10
Swiss Nordic Bio 2021